Source: Science Daily
Millions of people suffer cartilage damage to the knee every year. Cartilage injuries are not only painful; they can lead to osteoarthritis decades later. In the course of the disease, the protective shock absorbing cartilage that covers the bone within the joint slowly is removed until the bone is finally exposed, typically requiring an artificial joint replacement. A biotechnology company has developed a one-step minimally-invasive surgical procedure for the treatment of cartilage defects: a gel-like implant.
FDA approves Eliquis® (apixaban) to reduce the risk of blood clots following hip or knee replacement surgery
Source: Medical News Today
Bristol-Myers Squibb Company and Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.